Last reviewed · How we verify

NCT03745794

Repeat Quadratus Lumborum Block to Reduce Opioid Need in Patients After Pancreatic Surgery

Completed Phase 2 Results posted Last updated 23 December 2025
What this trial tests

Phase 2 trial testing Best Practice in Pancreatic Carcinoma in 136 participants. Completed in 31 July 2025.

Timeline
28 February 2019
Primary endpoint
31 July 2025
31 July 2025

Quick facts

Lead sponsorM.D. Anderson Cancer Center
PhasePhase 2
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingtriple
Primary purposetreatment
Enrollment136
Start date28 February 2019
Primary completion31 July 2025
Estimated completion31 July 2025
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

M.D. Anderson Cancer Center — full company profile →

Who can join

18 and older, any sex, with Pancreatic Carcinoma. Patients with the condition only — healthy volunteers not accepted.

Results — posted to ClinicalTrials.gov

Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.

Number of Participants Discharged Opioid-Free Primary · 90 days from surgery

Performed Chi-squared test to compare the proportion of patients who were opioid-free on the discharge date between the two arms

GroupValue95% CI
Arm 1, Control Arm (Usual Care)19
Arm 2, Experimental Arm (2nd QL-Block)27

Adverse events — posted to ClinicalTrials.gov

Time frame: 90 days from surgery. Reporting threshold: 1%. Adverse-event reports describe events observed during the trial — not all are caused by the drug.

Arm 1, Control Arm (Usual Care)
Serious: 10/52 (19%)
Deaths: 3/52
Arm 2, Experimental Arm (2nd QL-Block)
Serious: 10/54 (19%)
Deaths: 3/54

Serious adverse events (14 terms)

ReactionSystemArm 1, Control Arm (Usual …Arm 2, Experimental Arm (2…
Pancreatic leakGastrointestinal disorders
GI OtherGastrointestinal disorders
Chyle leakGastrointestinal disorders
AbscessInfections and infestations
SepsisInfections and infestations
Delayed Gastric EmptyingGastrointestinal disorders
BJ leakGastrointestinal disorders
PneumoniaRespiratory, thoracic and mediastinal disorders
Pulmonary OtherRespiratory, thoracic and mediastinal disorders
HemorrhageBlood and lymphatic system disorders
Hematologic_ otherBlood and lymphatic system disorders
Sterile collectionInfections and infestations
Line infectionInfections and infestations
Infectious OtherInfections and infestations
Other adverse events (20 terms — click to expand)

ReactionSystemArm 1, Control Arm (Usual …Arm 2, Experimental Arm (2…
GI OtherGastrointestinal disorders
Delayed Gastric EmptyingGastrointestinal disorders
Pancreatic leakGastrointestinal disorders
Wound infectionInfections and infestations
Infectious OtherInfections and infestations
Post-op transfusionBlood and lymphatic system disorders
Chyle leakGastrointestinal disorders
Renal otherRenal and urinary disorders
CholangitisInfections and infestations
ArrythmiaCardiac disorders
Hematologic_ otherBlood and lymphatic system disorders
Urinary Tract InfectionInfections and infestations
Neurologic_OtherNervous system disorders
PneumoniaRespiratory, thoracic and mediastinal disorders
EdemaRespiratory, thoracic and mediastinal disorders
HemorrhageBlood and lymphatic system disorders
Acute Renal FailureRenal and urinary disorders
AbscessInfections and infestations
ColitisInfections and infestations
Metabolic OtherMetabolism and nutrition disorders

Most-reported serious reactions: Pancreatic leak, GI Other, Chyle leak, Abscess, Sepsis, Delayed Gastric Emptying, BJ leak, Pneumonia.

Data from ClinicalTrials.gov NCT03745794 adverse events section.

Sponsor's own description

This phase II trial studies how an additional anesthetic nerve block, called a quadratus lumborum block, works to reduce the need for opioids in patients after pancreatic surgery. Giving an additional regional anesthetic after surgery may hasten the weaning process, reduce the need for opioid medications upon discharge, and reduce the risk of opioid dependence.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Sustained reduction in discharge opioid volumes through provider education: Results of 1168 cancer surgery patients over 2 years.
    Kim BJ, Newhook TE, Blumenthaler A, Chiang YJ, et al · · 2021 · cited 15× · PMID 33751605 · DOI 10.1002/jso.26476

Verify or expand the search:

Other trials of Best Practice

Trials testing the same drug.

Other recruiting trials for Pancreatic Carcinoma

Currently open trials in the same condition.

Other M.D. Anderson Cancer Center trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03745794.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing